
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 981 | 983 | 1271 | 1509 | 2086 | 3582 |
Fund Return | -1.89% | -1.72% | 27.08% | 14.71% | 15.84% | 13.61% |
Place in category | 860 | 587 | 52 | 131 | 565 | 359 |
% in Category | 79 | 53 | 4 | 16 | 62 | 50 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Alger Capital Appreciation Focus Fz | 1.4B | -1.88 | 16.96 | 16.62 | ||
Alger Spectra A | 1.13B | -1.93 | 14.32 | 13.25 | ||
Alger Capital Appreciation Instl I | 902.48M | -1.86 | 15.49 | 14.52 | ||
Alger Capital Appreciation A | 830.11M | -1.93 | 15.52 | 14.49 | ||
Alger Capital Appreciation Z | 811.68M | -1.90 | 15.96 | 14.89 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Funds Growth Fund Amer A | 133.69B | 1.21 | 12.52 | 13.33 | ||
Fidelity Contrafund | 144.79B | 3.52 | 17.24 | 15.17 | ||
Vanguard Growth Index Adm | 88.07B | -1.14 | 14.18 | 15.08 | ||
JPMorgan Large Cap Growth R6 | 60.28B | -0.18 | 15.79 | 17.17 | ||
Fidelity Blue Chip Growth | 61.8B | -2.84 | 15.11 | 17.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NVIDIA | US67066G1040 | 13.08 | 94.31 | -7.36% | |
Microsoft | US5949181045 | 12.79 | 359.84 | -3.56% | |
Amazon.com | US0231351067 | 8.98 | 171.00 | -4.15% | |
Meta Platforms | US30303M1027 | 7.01 | 504.73 | -5.06% | |
Apple | US0378331005 | 6.87 | 188.38 | -7.29% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Neutral |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review